| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |